Free Trial

NeueHealth, Inc. (NYSE:NEUE) Short Interest Update

NeueHealth logo with Medical background

Key Points

  • NeueHealth, Inc. saw a significant increase in short interest in July, rising by 142.3% to a total of 18,900 shares as of July 31st.
  • The company's stock price decreased by 2.4%, closing at $6.56 with a market capitalization of $59.17 million.
  • NeueHealth reported (-$1.68) earnings per share, despite exceeding analysts' expectations, with revenue of $209.08 million for the quarter.
  • Five stocks to consider instead of NeueHealth.

NeueHealth, Inc. (NYSE:NEUE - Get Free Report) saw a large increase in short interest during the month of July. As of July 31st, there was short interest totaling 18,900 shares, anincreaseof142.3% from the July 15th total of 7,800 shares. Based on an average daily trading volume, of 6,700 shares, the days-to-cover ratio is currently 2.8 days. Currently,0.6% of the shares of the company are sold short. Currently,0.6% of the shares of the company are sold short. Based on an average daily trading volume, of 6,700 shares, the days-to-cover ratio is currently 2.8 days.

Hedge Funds Weigh In On NeueHealth

Several hedge funds have recently made changes to their positions in NEUE. PenderFund Capital Management Ltd. purchased a new position in shares of NeueHealth in the first quarter worth approximately $197,000. Skandinaviska Enskilda Banken AB publ purchased a new position in shares of NeueHealth in the second quarter worth approximately $201,000. Finally, Northern Trust Corp increased its position in shares of NeueHealth by 66.8% in the fourth quarter. Northern Trust Corp now owns 32,644 shares of the company's stock worth $242,000 after acquiring an additional 13,074 shares in the last quarter. Institutional investors and hedge funds own 63.88% of the company's stock.

NeueHealth Trading Up 0.5%

NYSE:NEUE traded up $0.0350 during mid-day trading on Thursday, hitting $6.5850. The stock had a trading volume of 7,612 shares, compared to its average volume of 16,765. The stock has a market capitalization of $59.40 million, a price-to-earnings ratio of -0.41 and a beta of 0.57. The company has a 50 day simple moving average of $6.80 and a 200-day simple moving average of $6.77. NeueHealth has a 52 week low of $3.79 and a 52 week high of $7.66.

NeueHealth (NYSE:NEUE - Get Free Report) last issued its quarterly earnings data on Thursday, August 7th. The company reported ($1.68) earnings per share for the quarter, beating the consensus estimate of ($4.77) by $3.09. The firm had revenue of $209.08 million during the quarter, compared to the consensus estimate of $249.50 million. As a group, equities research analysts anticipate that NeueHealth will post -9.13 earnings per share for the current year.

NeueHealth Company Profile

(Get Free Report)

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.

Further Reading

Should You Invest $1,000 in NeueHealth Right Now?

Before you consider NeueHealth, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NeueHealth wasn't on the list.

While NeueHealth currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.